This course type is laboratory

Molecular Pathology and Diagnosis of Cancer

09 - 14 October 2016Wellcome Genome Campus, Hinxton, UK
Deadlines (at 23:59 UTC):
  • Application Deadline Closed

  • Summary

    A joint initiative of the Wellcome Genome Campus and the RCPath Interspecialty Committee on Molecular Pathology, this course is aimed primarily at trainee pathologists or haematologists. The programme introduces participants to the rapidly evolving field of the molecular diagnosis of cancer. Clinical scientists entering the field of molecular diagnosis are also encouraged to apply.

    The course consists of a series of practical sessions covering current
    diagnostic methodologies, along with hands-on training in bioinformatics
    tools and techniques for analysis of sequence data.

    In addition, the programme includes talks and demonstrations of next
    generation sequencing platforms (including the latest developments in
    genomic technologies) as well as discussions on the ethical, societal and
    practical implications of introducing genome-wide genetic analyses to the
    clinic.

    The course will also host a number of leading national and international
    speakers who will give lectures on the molecular pathology of a number of
    cancers, including lung, colorectal, leukaemia, myeloma and others.

    PLEASE NOTE: Limited bursaries are available for
    clinical and academic applicants from anywhere in the world to attend
    this course and are awarded on merit. In addition, CPD accreditation will
    be sought from the Royal College of Pathologists.

    Feedback from the 2015 course

    -This is a hugely important course to run in terms of increasing
    awareness of molecular pathology diagnostics amongst
    cellular pathologists and consequently development of NHS services
    incorporating molecular cancer diagnostics.
    -Thank you, executed to a high standard!
    -A very special thank you to all organisers for putting together such an
    excellent course with a good balance between
    practical sessions, theory and discussions.
    -It was a fantastic course with excellent organization.
    -Excellent course, really helpful. Thank you very much.
    -One of the best courses I have attended, would like to attend similar
    courses.

  • Programme

    The programme will include lecture and laboratory/computer-based
    practical sessions covering the following topics:

    • Standard and real-time PCR
    • DNA electrophoresis
    • Capillary (Sanger) sequencing
    • Fluorescence in situ hybridisation (FISH)
    • State-of-the-art next-generation sequencing technologies
    • Target enrichment approaches
    • Bioinformatic analysis for mutation detection

    Learning outcomes

    It is anticipated that by the end of the course, participants will have
    sufficient knowledge of current and future molecular methodologies
    applied to cancer diagnosis to be able to participate in the impending
    revolution in the practice of clinical pathology and haematology.
    Particpants will also gain an understanding of the structure
    of next
    generation sequencing data, and the use of analysis tools and
    publicly-available databases to interpret these data for diagnosis and
    prognosis of patients.

    Finally, the course hopes to inspire trainees to follow a career in
    genomic cancer medicine and research.

    CPD Accreditation
    CPD accreditation will be sought from the Royal College of
    Pathologists.

  • Instructors / Speakers

    Course instructors
    George
    Vassiliou
    Wellcome Trust Sanger Institute, UK
    Anthony Bench, Addenbrooke’s Hospital, Cambridge, UK
    Bridget Manasse, Addenbrooke’s Hospital, Cambridge, UK
    Peter Ellis, Wellcome Trust Sanger Institute, UK
    Michael
    Quail
    Wellcome Trust Sanger Institute, UK
    Elli
    Papaemmanuil
    Memorial Sloan Kettering Cancer Center, USA

    Guest speakers
    Charlie
    Massie
    Cambridge Cancer Centre, University of Cambridge, UK
    Manuel
    Salto-Tellez
    Queen’s University Belfast, UK
    Mark
    Arends
    University of Edinburgh, UK
    Ian Cree, Warwick Medical School, UK
    James
    Brenton
    Cancer Research UK Cambridge Institute, UK
    Anna
    Middleton
    Wellcome Trust Sanger Institute, UK
    Marc
    Tischkowitz
    University of Cambridge, UK

  • How to Apply

    Prerequisites
    Applicants should be trainee pathologists or haematologists, or clinical
    scientists considering a career in molecular pathology/diagnosis.

    Cost
    The
    course is subsidised by the Wellcome Genome Campus
    Advanced Courses and Scientific Conferences Programme. This is a
    residential
    course and there is a fee of £745 towards board and lodging
    for non-commercial applicants. Please contact us for the commercial fee.

    Additional limited bursaries are available (up to 50% of the course fee)
    and are awarded on merit. Please see the “Bursaries” tab for details.

    Applications
    Applications for this course can be completed online. If you have any
    problems with the online application process, please contact us.

    Please note: Applications
    must be supported by a
    recommendation from a scientific or clinical sponsor (e.g. supervisor or
    head of department). A request for a supporting
    statement will be sent
    to your nominated sponsor automatically during
    the application process.
    Applicants must ensure that their sponsor
    provides this supporting
    statement by the application deadline. Applications without a supporting
    statement cannot be considered.

    Deadlines
    Closed

  • Bursaries

    Bursaries
    Advanced Courses are subsidised for non-commercial
    applicants from anywhere in the world. Additional, limited bursaries are
    available (up to 50% of the course fee) and are awarded on merit. If you
    would like to apply for a
    bursary, please complete the bursary section
    of the online application
    form.

    Please note that both the applicant
    and sponsor are required to provide
    a justification for the
    bursary as part of the application.

    Bursary terms and conditions

    UK Courses (held at the Wellcome Genome Campus, Hinxton,
    Cambridge)
    A
    limited number of bursaries are available for each course. These are
    awarded by the selection committee according to merit. The bursary
    covers a maximum of 50% of the course fee, though in exceptional
    circumstances an application for the total course fee may be considered.
    Where there are many bursary applications, the selection committee may
    issue smaller amounts. We cannot assist with travel costs to attend UK
    courses.

    Overseas Courses (held outside of the UK)
    A
    limited number of bursaries are available for each course. These are
    awarded on merit to cover travel, accommodation and sustenance. The
    maximum award for travel (economy class) will be £750.

    Bursaries can be applied for as part of the course application form.
    Applicants
    will be notified of a bursary award along with their place on
    the
    course, usually within one month of the application deadline. The
    decision of the selection committee is
    final.